Atlas Trials

Study Multicentre Evaluating the Effectiveness and Toxicity Sorafenib (Nexavar®) in Adult Patients With Uveal Melanoma and Metastatic Dissemination

Clinical trial NCT02517736 · COMPLETED

Trial details

NCT number
NCT02517736
Sponsor
University Hospital, Caen
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Uveal Melanoma
Start date
2012-02-01
Primary completion
2015-01-13
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.